Mutational Landscape Determines Sensitivity to PD-1 Blockade in Non-Small Cell Lung Cancer

Patients with non-small cell lung cancer were treated with pembrolizumab. Their tumors and matched normal blood were sequenced.

• Type: Cohort
• Archiver: The database of Genotypes and Phenotypes (dbGaP)